CLL Comprehensive Panel near me in Asansol

For men & women

Earliest reports in

216 hours

Contains

6 tests

Know more about this test

The CLPD (Chronic Lymphoproliferative Disorders) Flow Panel is a flow cytometry-based diagnostic test used to analyze the immunophenotypic characteristics of lymphocytes in patients suspected of having chronic lymphoproliferative disorders, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and other related diseases. This panel examines various cell surface markers and intracellular proteins to identify aberrant populations of lymphocytes and determine their immunophenotypic profiles. The results help in diagnosing and classifying specific lymphoproliferative disorders, guiding treatment decisions, and monitoring disease progression in patients with these conditions. CLL FISH testing provides information about the genetic profile of the patient's CLL cells. This genetic information can help doctors determine the appropriate treatment strategy and assess the prognosis. It's important to note that CLL is a heterogeneous disease, and FISH testing is one of several diagnostic and prognostic tools used to guide the management of this condition.

Samples required

Blood

Preparation for this test

Sample Collection

Who will collect your samples?

What does CLL Comprehensive Panel measure?

Contains 6 tests

CLPD Basic

The CLPD Basic measures multiple cell surface markers (antigens) on white blood cells to detect abnormal patterns in lymphocyte populations. It uses Flow Cytometry, a technique that evaluates the physical and chemical characteristics of cells in a fluid as they pass through lasers. This allows the test to determine the type of cells, their number, size, shape, and the presence of specific surface markers.

In the context of CLPD, Flow Cytometry helps identify whether the disorder involves B-cells, T-cells, or other lymphocyte types, and analyzes markers such as CD5, CD10, CD19, CD20, CD23, CD38, FM7, Kappa, Lambda, CD100, among others. These markers provide important information for classifying the type of lymphoproliferative disorder, assessing its aggressiveness, and differentiating between various forms of leukemia. By combining cell counts, physical characteristics, and marker expression, this test enables doctors to diagnose the disorder accurately, monitor treatment response, and guide personalized therapy decisions.

Know more about CLPD Basic